Brii Biosciences Ltd
HKEX:2137
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Brii Biosciences Ltd
HKEX:2137
|
CN |
|
Mercedes-Benz Group AG
MIL:1MBG
|
DE |
|
Cicor Technologies Ltd
SIX:CICN
|
CH |
|
Breakthrough Minerals Ltd
ASX:BTM
|
AU |
|
Aym Syntex Ltd
NSE:AYMSYNTEX
|
IN |
|
S
|
Suncor Energy Inc (Canada)
DUS:SM3
|
CA |
|
A
|
Amerisafe Inc
F:A3I
|
US |
|
W
|
Walmart Inc
DUS:WMT
|
US |
|
A
|
AECI Ltd
JSE:AFE
|
ZA |
|
Loop Industries Inc
F:3L9
|
CA |
|
Toda Corp
TSE:1860
|
JP |
|
Coherent Corp
MIL:1COHR
|
US |
|
C
|
Churchill Resources Inc (ON)
XTSX:CRI
|
CA |
|
Condor Energies Inc
TSX:CDR
|
CA |
|
Entera Bio Ltd
F:5DT
|
IL |
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
J
|
Jiangsu Financial Leasing Co Ltd
SSE:600901
|
CN |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
M
|
Murphy Oil Corp
XMUN:MUQ
|
US |
|
N
|
Nucor Corp
XMUN:NUO
|
US |
|
A
|
Aston Martin Lagonda Global Holdings PLC
OTC:ARGGY
|
UK |
|
Schneider Electric SE
PAR:SU
|
FR |
|
ING Groep NV
AEX:INGA
|
NL |
|
H
|
Heidelberg Materials AG
DUS:HEI
|
DE |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Brii Biosciences Ltd.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Brii Biosciences Does
Brii Biosciences is a biopharmaceutical company that focuses on medicines for serious infectious diseases. Its main work is discovering, developing, and trying to commercialize treatments for conditions such as hepatitis B, HIV, and drug-resistant infections. It is not a broad drugmaker; it is centered on a small set of hard-to-treat diseases where new therapies are still needed.
- Headquarters
- China CN
- Employees
- 75
- IPO date
- Jul 13, 2021